NM_001128423.2:c.56C>A
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_001128423.2(MPV17L):c.56C>A(p.Thr19Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000333 in 1,500,220 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001128423.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MPV17L | NM_001128423.2 | c.56C>A | p.Thr19Asn | missense_variant | Exon 1 of 4 | ENST00000396385.4 | NP_001121895.1 | |
MPV17L-BMERB1 | NM_001414674.1 | c.56C>A | p.Thr19Asn | missense_variant | Exon 1 of 6 | NP_001401603.1 | ||
MPV17L | NM_173803.4 | c.56C>A | p.Thr19Asn | missense_variant | Exon 1 of 3 | NP_776164.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MPV17L | ENST00000396385.4 | c.56C>A | p.Thr19Asn | missense_variant | Exon 1 of 4 | 1 | NM_001128423.2 | ENSP00000379669.3 | ||
ENSG00000261130 | ENST00000568766.1 | c.56C>A | p.Thr19Asn | missense_variant | Exon 1 of 2 | 2 | ENSP00000454340.1 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152212Hom.: 0 Cov.: 32
GnomAD4 exome AF: 7.42e-7 AC: 1AN: 1348008Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 664834
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152212Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74360
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.56C>A (p.T19N) alteration is located in exon 1 (coding exon 1) of the MPV17L gene. This alteration results from a C to A substitution at nucleotide position 56, causing the threonine (T) at amino acid position 19 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at